Chen Po-Hong, Hsueh Hsiu-Fang, Hong Chang-Zern
Department of Physical Medicine and Rehabilitation, Kuo General Hospital, Tainan, Taiwan.
Arch Phys Med Rehabil. 2002 Nov;83(11):1624-8. doi: 10.1053/apmr.2002.34602.
(1) To describe the demographic features of patients with voiding dysfunction associated with herpes zoster; (2) to discuss the pathophysiology of voiding dysfunction associated with herpes zoster; and (3) to suggest the best management policy.
A retrospective study.
A university-affiliated medical center in Taiwan.
Four hundred twenty-three patients (mean age, 55.5y) admitted with the diagnosis of herpes zoster from 1988 to 2000.
Not applicable.
Dermatomal distribution of skin eruptions, urologic symptoms, treatment (catheterization, urecholine), clinical course of voiding dysfunction, and outcome.
Seventeen (mean age, 61.2+/-14.1y) of 423 patients (4.02%) with voiding dysfunction related to this virus infection were identified. Ten (58.8%) were men, and 7 (41.2%) were women. The incidence of dysfunction was as high as 28.6% if only lumbosacral dermatome-involved patients were considered. We classified urologic manifestations caused by herpes zoster into 3 groups: cystitis-associated (n=12), neuritis-associated (n=4), and myelitis-associated (n=1). Urinalysis revealed pyuria in all patients with cystitis-associated voiding dysfunction and microscopic hematuria in all patients with neuritis-associated voiding dysfunction. All patients, although receiving different treatment regimens for voiding dysfunction, regained a normal or balanced bladder within 8 weeks. No major urologic sequelae were noted.
Voiding dysfunction, although a transient course, is not uncommon in patients with herpes zoster involving lumbosacral dermatomes. Treatment with intermittent catheterization (our preferred choice) or indwelling catheter placement is recommended if the patients have prolonged difficulty in urination. This disease entity usually has a benign clinical course, and almost every patient will either regain normal voiding or, at least, balanced bladder function.
(1)描述与带状疱疹相关的排尿功能障碍患者的人口统计学特征;(2)探讨与带状疱疹相关的排尿功能障碍的病理生理学;(3)提出最佳管理策略。
一项回顾性研究。
台湾一所大学附属医院。
1988年至2000年期间收治的423例诊断为带状疱疹的患者(平均年龄55.5岁)。
不适用。
皮肤疹的皮节分布、泌尿系统症状、治疗(导尿、乌拉胆碱)、排尿功能障碍的临床病程及结局。
423例与该病毒感染相关的排尿功能障碍患者中,有17例(平均年龄61.2±14.1岁)被确诊(4.02%)。10例(58.8%)为男性,7例(41.2%)为女性。若仅考虑累及腰骶部皮节的患者,功能障碍的发生率高达28.6%。我们将带状疱疹引起的泌尿系统表现分为3组:膀胱炎相关组(n = 12)、神经炎相关组(n = 4)和脊髓炎相关组(n = 1)。尿液分析显示,所有膀胱炎相关排尿功能障碍患者均有脓尿,所有神经炎相关排尿功能障碍患者均有镜下血尿。所有患者尽管接受了不同的排尿功能障碍治疗方案,但均在8周内恢复了正常或平衡的膀胱功能。未发现严重的泌尿系统后遗症。
排尿功能障碍在累及腰骶部皮节的带状疱疹患者中并不少见,尽管病程短暂。如果患者排尿困难持续时间较长,建议采用间歇性导尿(我们的首选)或留置导尿治疗。这种疾病通常具有良性临床病程,几乎每位患者要么恢复正常排尿,要么至少恢复膀胱功能平衡。